Advisory Alpha, LLC Abbott Laboratories Transaction History

Advisory Alpha, LLC

$2.78 Billion
Q3 2024

A detailed history of Advisory Alpha, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Advisory Alpha, LLC holds 6,162 shares of ABT stock, worth $725,637. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,162

Previous 5,922 4.05%

Holding current value

$725,637

Previous $615,000 14.15%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $24,016 - $28,351	240 Added 4.05%	6,162 $702,000
Q2 2024 Aug 21, 2024	SELL	$100.73 - $112.44 $16,821 - $18,777	-167 Reduced 2.74%	5,922 $615,000
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $225,282 - $248,814	2,057 Added 51.02%	6,089 $692,000
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $118,058 - $144,513	1,309 Added 48.07%	4,032 $443,000
Q3 2023 Oct 18, 2023	SELL	$95.53 - $114.62 $74,799 - $89,747	-783 Reduced 22.33%	2,723 $263,000
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $11,992 - $13,362	-119 Reduced 3.28%	3,506 $382,000
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $178,125 - $209,664	-1,839 Reduced 33.66%	3,625 $367,000
Q4 2022 Jan 30, 2023	BUY	$95.06 - $111.52 $11,026 - $12,936	116 Added 2.17%	5,464 $600,000
Q3 2022 Oct 12, 2022	BUY	$96.76 - $112.03 $193 - $224	2 Added 0.04%	5,348 $518,000
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $3,368 - $4,071	33 Added 0.62%	5,346 $581,000
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $12,086 - $14,738	106 Added 2.04%	5,313 $629,000
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $116,107 - $142,167	1,005 Added 23.92%	5,207 $733,000
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $19,482 - $21,553	167 Added 4.14%	4,202 $496,000
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $201,424 - $237,105	1,904 Added 89.35%	4,035 $468,000
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $61,929 - $72,962	-569 Reduced 21.07%	2,131 $255,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $60,165 - $65,562	573 Added 26.94%	2,700 $296,000
Q3 2020 Nov 06, 2020	SELL	$91.64 - $111.29 $126,829 - $154,025	-1,384 Reduced 39.42%	2,127 $754,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $268,837 - $344,078	3,511 New	3,511 $353,000
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $160,567 - $234,794	-2,556 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $13,896 - $15,469	-177 Reduced 6.48%	2,556 $218 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1,145 - $1,242	-14 Reduced 0.51%	2,733 $228,000
Q2 2019 Aug 16, 2019	BUY	$72.88 - $85.0 $20,260 - $23,630	278 Added 11.26%	2,747 $240,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $163,497 - $197,668	2,469 New	2,469 $0

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.

Account

Advisory Alpha, LLC Abbott Laboratories Transaction History